VectorFlu™ ONE Granted Emergency Use Authorization in mainland

VectorFlu ONE, a nasal spray COVID-19 vaccine, has been granted emergency use authorization in the Chinese mainland, its developer announced on Monday. Analysis of interim primary data from its Phase III clinical trial showed that the vaccine provided good protection against Omicron variant strains BA.2, BA.4 and BA.5.